Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
    Users Online: 98
Home Print this page Email this page Small font size Default font size Increase font size
Year : 2020  |  Volume : 9  |  Issue : 1  |  Page : 56-60

Prevalence of hepatitis B and hepatitis C viral infections and impact of control program among blood donors in Al-Baha region, Saudi Arabia

1 Departments of Medical Microbiology, Faculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia
2 Department of Medicine, Faculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia
3 Department of Biochemistry, Faculty of Medicine, Al-Baha University, Al-Baha, Kingdom of Saudi Arabia
4 Central Laboratory and Blood Bank, Al-Baha, Kingdom of Saudi Arabia

Correspondence Address:
Prof. Talal A Sallam
Department of Medical Microbiology, Faculty of Medicine, Al-Baha University, P. O. Box: 1988, Al-Baha
Kingdom of Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/sjhs.sjhs_197_19

Rights and Permissions

Background: A low prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections has been previously reported in Al-Baha. The present study reexamines the prevalence of HBV and HCV infection among blood donors 3 years following a previous study in an attempt to detect an impact of control measures. Materials and Methods: This 29-month retrospective study was conducted from October 2014 to May 2017. A total of 3,461 blood donors were screened for serological and molecular markers for HBV and HCV. Results: The mean age of the donors was 32.4 ± 10. 1 (range: 17–67). Of all donors 10 (0.3%) had HBsAg while 253 (7.3%) had anti-HBc in absence of HBsAg. Anti-HCV was detected in 8 (0.2%) donors, of whom 6 (75.0%) were also HCV-RNA positive. HBV-DNA was detected in 12 (0.4%) donors, of whom 10 (83.3%) had concurrent HBsAg, whereas 2 (16.7%) had HBV-DNA with anti-HBc as the only HBV marker. The donors born after inclusion of HBV vaccine in expanded program of immunization (EPI) had a significantly (P < 0.05) lower prevalence of HBsAg, anti-HBc, and HBV-DNA. Although insignificant (P = 0.197), a lower prevalence of HCV infection was detected among the donors who were born after implementing the screening policy for HCV infection. Conclusion: Compared to a previous report, this study detected a further reduction in the prevalence of HBV, whereas the decline of the prevalence of HCV infection merits further investigation.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded201    
    Comments [Add]    

Recommend this journal